Stoke Therapeutics Inc
General ticker "STOK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $687.2M
Stoke Therapeutics Inc follows the US Stock Market performance with the rate: 45.7%.
Estimated limits based on current volatility of 4.6%: low 10.65$, high 11.68$
Factors to consider:
- Current price 35.3% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.13$, 8.58$]
- 2024-12-30 to 2025-12-30 estimated range: [4.00$, 10.03$]
Financial Metrics affecting the STOK estimates:
- Negative: Non-GAAP EPS, $ of -2.37 <= 0.10
- Negative: Operating profit margin, % of -92.89 <= 1.03
- Negative: Operating cash flow per share per price, % of -28.36 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
Short-term STOK quotes
Long-term STOK plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $12.40MM | $8.78MM |
Operating Expenses | $86.06MM | $116.76MM | $123.55MM |
Operating Income | $-86.06MM | $-104.36MM | $-114.77MM |
Non-Operating Income | $0.26MM | $3.29MM | $10.07MM |
Interest Expense | $0.12MM | $3.12MM | $0.00MM |
R&D Expense | $54.17MM | $77.84MM | $82.23MM |
Income(Loss) | $-85.81MM | $-101.07MM | $-104.70MM |
Profit(Loss) | $-85.81MM | $-101.07MM | $-104.70MM |
Stockholders Equity | $217.78MM | $184.85MM | $159.56MM |
Inventory | $0.00MM | $10.93MM | $0.00MM |
Assets | $238.87MM | $256.07MM | $228.34MM |
Operating Cash Flow | $-66.91MM | $-31.87MM | $-81.07MM |
Capital expenditure | $1.20MM | $3.96MM | $1.62MM |
Investing Cash Flow | $-76.43MM | $-45.88MM | $105.95MM |
Financing Cash Flow | $1.28MM | $46.41MM | $53.01MM |
Earnings Per Share* | $-2.31 | $-2.39 | $-2.38 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.